Introduction

Acta Diabetol. 2005 Apr:42 Suppl 1:S1-2. doi: 10.1007/s00592-005-0174-2.
No abstract available

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Benzimidazoles / therapeutic use
  • Benzoates / therapeutic use
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / prevention & control
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetic Nephropathies / complications*
  • Diabetic Nephropathies / drug therapy
  • Humans
  • Hypertension / complications*
  • Hypertension / drug therapy
  • Hypoglycemic Agents / therapeutic use
  • Obesity / complications*
  • Obesity / drug therapy
  • Telmisartan

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Benzimidazoles
  • Benzoates
  • Hypoglycemic Agents
  • Telmisartan